Target-specific drug release to the colon

被引:40
作者
Jain, Sanjay K. [1 ]
Jain, Anekant [1 ]
机构
[1] Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Pharmaceut Res Projects Lab, Sagar 470003, MP, India
关键词
biodegradable polymers; colon delivery; colon drug delivery system; colonic microlflora;
D O I
10.1517/17425247.5.5.483
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The ability to deliver drugs to the human colon in a specific manner has become feasible over the years. Targeting pharmaceutical drugs to the colon makes it possible to achieve local or systemic drug delivery to this site. Objective: To deliver the compounds in a non-degraded form to the lower part of the gastrointestinal tract, they must first pass through the stomach and the upper part of the intestine before releasing the contents in the colon. Methods: This review provides an overview of the various approaches to targeted drug delivery to the colon using different drug delivery systems, their limitations and the future developments in this field. Results/conclusions: A microbially controlled system, which is a well-accepted approach, based on natural polymers, has the greatest potential for colonic delivery, particularly in terms of site specificity and safety. However, close attention should be paid to the performance of these products in the heterogeneous environment of the human gastrointestinal tract.
引用
收藏
页码:483 / 498
页数:16
相关论文
共 113 条
[101]   MEASUREMENT OF THEOPHYLLINE ABSORPTION FROM DIFFERENT REGIONS OF THE GASTROINTESTINAL-TRACT USING A REMOTE CONTROLLED DRUG DELIVERY DEVICE [J].
STAIB, AH ;
LOEW, D ;
HARDER, S ;
GRAUL, EH ;
PFAB, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (06) :691-697
[102]   MICROBIAL CONTRIBUTION TO HUMAN FECAL MASS [J].
STEPHEN, AM ;
CUMMINGS, JH .
JOURNAL OF MEDICAL MICROBIOLOGY, 1980, 13 (01) :45-&
[103]  
Swanson D R, 1987, Am J Med, V83, P3, DOI 10.1016/0002-9343(87)90629-2
[104]   Importance of dissolution process on systemic availability of drugs delivered by colon delivery system [J].
Takaya, T ;
Niwa, K ;
Muraoka, M ;
Ogita, I ;
Nagai, N ;
Yano, R ;
Kimura, G ;
Yoshikawa, Y ;
Yoshikawa, H ;
Takada, K .
JOURNAL OF CONTROLLED RELEASE, 1998, 50 (1-3) :111-122
[105]  
THEEUWES F, 1990, Patent No. 4904474
[106]  
Van den Mooter G., 1995, Drug Delivery, V2, P81, DOI 10.3109/10717549509031355
[107]   The use of polysaccharides to target drugs to the colon [J].
Vandamme, TF ;
Lenourry, A ;
Charrueau, C ;
Chaumeil, J .
CARBOHYDRATE POLYMERS, 2002, 48 (03) :219-231
[108]   THE RELATION BETWEEN SWELLING PROPERTIES AND ENZYMATIC DEGRADATION OF AZO POLYMERS DESIGNED FOR COLON-SPECIFIC DRUG-DELIVERY [J].
VANDENMOOTER, G ;
SAMYN, C ;
KINGET, R .
PHARMACEUTICAL RESEARCH, 1994, 11 (12) :1737-1741
[109]   FECAL FLORA IN ULCERATIVE-COLITIS [J].
VANDERWIELKORSTANJE, JAA ;
WINKLER, KC .
JOURNAL OF MEDICAL MICROBIOLOGY, 1975, 8 (04) :491-501
[110]   INVIVO EVALUATION OF ENTERIC-COATED NAPROXEN TABLETS USING GAMMA SCINTIGRAPHY [J].
WILDING, IR ;
HARDY, JG ;
SPARROW, RA ;
DAVIS, SS ;
DALY, PB ;
ENGLISH, JR .
PHARMACEUTICAL RESEARCH, 1992, 9 (11) :1436-1441